The Effects of Probiotic Supplementation on Level of Disability, Depressive Symptoms, and Cognitive Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: A Randomized Double-Blind Placebo-Controlled Trial
Background: Multiple sclerosis (MS) is a chronic autoimmune disease characterized by inflammation and demyelination of the central nervous system. Probiotics, through the gut-brain axis, are suggested to enhance clinical outcomes in patients with MS. This study scrutinizes the effects of probiotic s...
Saved in:
| Main Authors: | Amirreza Naseri, Sarvin Sanaie, Sama Rahnemayan, Reza Mosaddeghi-Heris, Malihe Talebi, Mahnaz Talebi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tabriz University of Medical Sciences
2025-07-01
|
| Series: | Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://ps.tbzmed.ac.ir/PDF/ps-31-322.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01) -
The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01) -
Experience with the long-term use of interferons β in the treatment of relapsing-remitting multiple sclerosis. Case report
by: Taras O. Simaniv, et al.
Published: (2024-12-01) -
Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
by: Barbara Polistena, et al.
Published: (2025-06-01) -
Role of Diet and Supplementation with Omega-3 Polyunsaturated Fatty Acids for Managing Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis
by: Nicholas Shepherd, et al.
Published: (2022-11-01)